Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study.

BACKGROUND Aminoglycosides (AG) cause acute kidney injury (AKI), but the incidence and severity distribution are unclear, particularly in non-critically ill children. We determined the incidence, severity and risk factors of AG-associated AKI and assessed for associations with longer hospitalization and higher costs. METHODS At Texas Children's Hospital, we conducted a retrospective cohort study of children treated with AG for ≥ 5 days in 2005, excluding children with admission primary renal diagnoses. AKI was defined by the paediatric Risk, Injury, Failure, Loss, End Stage Kidney Disease (pRIFLE) and Acute Kidney Injury Network (AKIN) definitions. Multiple logistic and linear regression analyses were used to assess independence of associations with outcomes. RESULTS Five hundred and fifty-seven children [mean ± SD age = 8.0 ± 5.9 years, 286 (51%) male, 489 (88%) gentamicin] were studied. The AKI rate was 33% and 20% by pRIFLE and AKIN definitions, respectively. Longer treatment, higher baseline estimated glomerular filtration rate, being on a medicine (versus surgical) treatment service and prior AG treatment were independent risk factors for AKI development. AKI by pRIFLE or AKIN was independently associated with longer hospital stay and higher total hospital costs. The pRIFLE definition was more sensitive for AKI detection, but the AKIN definition was more strongly related to outcomes. CONCLUSIONS AKI is common and associated with poorer outcomes in non-critically ill children treated with AG. Future research should attempt to understand how to best define AKI in the non-critical illness paediatric setting.

[1]  F. Plötz,et al.  Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE criteria , 2008, Intensive Care Medicine.

[2]  I. Clifton,et al.  Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  G. Lönnerholm,et al.  Renal function after autologous bone marrow transplantation in children: a long-term prospective study , 2002, Bone Marrow Transplantation.

[4]  S. Goldstein,et al.  Ascertainment and epidemiology of acute kidney injury varies with definition interpretation. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[5]  P. Davis,et al.  The Association of Renal Dysfunction and the Use of Aprotinin in Patients Undergoing Congenital Cardiac Surgery Requiring Cardiopulmonary Bypass , 2009, Anesthesia and analgesia.

[6]  Joseph V Bonventre,et al.  Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. , 2005, Journal of the American Society of Nephrology : JASN.

[7]  P. Metnitz,et al.  Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database , 2009, Intensive Care Medicine.

[8]  R. Khemani,et al.  Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit , 2010, Critical care medicine.

[9]  Sudhir V. Shah,et al.  Reactive oxygen metabolites in toxic acute renal failure. , 1992, Renal failure.

[10]  G. Drusano,et al.  Prospective Evaluation of the Effect of an Aminoglycoside Dosing Regimen on Rates of Observed Nephrotoxicity and Ototoxicity , 1999, Antimicrobial Agents and Chemotherapy.

[11]  John A Kellum,et al.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury , 2007, Critical care.

[12]  C. Hassager,et al.  Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  P. Speelman,et al.  Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients , 1997, Clinical pharmacology and therapeutics.

[14]  A. Elhan,et al.  Application of the new classification criteria of the Acute Kidney Injury Network: a pilot study in a pediatric population , 2009, Pediatric Nephrology.

[15]  R. Bellomo,et al.  Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group , 2004, Critical care.

[16]  L S Jefferson,et al.  Modified RIFLE criteria in critically ill children with acute kidney injury. , 2007, Kidney international.

[17]  A. Levin,et al.  Acute kidney injury: toward an integrated understanding through development of a research agenda. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[18]  N. Pannu,et al.  An overview of drug-induced acute kidney injury , 2008, Critical care medicine.

[19]  P. Kosalaraksa,et al.  Once-daily gentamicin dosing of 4 Mg/Kg/dose in neonates. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[20]  P. Tulkens,et al.  Aminoglycosides: Nephrotoxicity , 1999, Antimicrobial Agents and Chemotherapy.

[21]  C. Ronco,et al.  North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE Criteria. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[22]  D. Greenhalgh,et al.  An assessment of acute kidney injury with modified RIFLE criteria in pediatric patients with severe burns , 2009, Intensive Care Medicine.

[23]  Christopher H Schmid,et al.  Evaluating the performance of equations for estimating glomerular filtration rate. , 2008, Journal of nephrology.

[24]  C. Kirkpatrick,et al.  The Use of a Change in Gentamicin Clearance as an Early Predictor of Gentamicin‐Induced Nephrotoxicity , 2003, Therapeutic drug monitoring.

[25]  R. Bellomo,et al.  An assessment of the RIFLE criteria for acute renal failure in hospitalized patients* , 2006, Critical care medicine.

[26]  M. Rupp,et al.  Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity , 2004, Critical care medicine.

[27]  D. Warkentin,et al.  Toxicity of single daily dose gentamicin in stem cell transplantation , 1999, Bone Marrow Transplantation.

[28]  Ming-Yang Chang,et al.  ACUTE KIDNEY INJURY CLASSIFICATION: COMPARISON OF AKIN AND RIFLE CRITERIA , 2010, Shock.

[29]  B. Ali,et al.  Gentamicin nephrotoxicity in humans and animals: some recent research. , 1995, General pharmacology.

[30]  P. Tulkens,et al.  Aminoglycosides: Activity and Resistance , 1999, Antimicrobial Agents and Chemotherapy.

[31]  K. Tsuchiya,et al.  A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT , 2010, Bone Marrow Transplantation.

[32]  D. Leehey,et al.  Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy. , 1993, Journal of the American Society of Nephrology : JASN.

[33]  Susan L Furth,et al.  New equations to estimate GFR in children with CKD. , 2009, Journal of the American Society of Nephrology : JASN.

[34]  S. Goldstein,et al.  Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  M. Walshaw,et al.  Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use , 2005, Pediatric pulmonology.

[36]  Y. Almog,et al.  Pharmacokinetic dosing of aminoglycosides: a controlled trial. , 2003, The American journal of medicine.

[37]  R. Tight,et al.  Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients. , 1996, The American journal of medicine.

[38]  J. Kellum,et al.  Modern Classification of Acute Kidney Injury , 2010, Blood Purification.

[39]  G. Patel,et al.  An Evaluation of Amikacin Nephrotoxicity in the Hematology/Oncology Population , 2008, American journal of therapeutics.

[40]  D. Spencer,et al.  The effects of intravenous tobramycin on renal tubular function in children with cystic fibrosis. , 2005, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[41]  S. Goldstein,et al.  3-5 year longitudinal follow-up of pediatric patients after acute renal failure. , 2006, Kidney international.

[42]  A. Alvarez,et al.  Acute kidney injury in intensive care unit patients: a comparison between the RIFLE and the Acute Kidney Injury Network classifications , 2008, Critical care.

[43]  H. Bruining,et al.  Experience with a once-daily dosing program of aminoglycosides in critically ill patients , 2002, Intensive Care Medicine.

[44]  C. Rademaker,et al.  Once-Daily Versus Multiple-Daily Gentamicin in Infants and Children , 2001, Therapeutic drug monitoring.

[45]  A. Derakhshan,et al.  Risk of Nephropathy After Consumption of Nonionic Contrast Media by Children Undergoing Cardiac Angiography: A Prospective Study , 2010, Pediatric Cardiology.